Record Attendance, Agenda Open WHO Board Meeting; Global Vision On Infectious Disease 25/01/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Response to diseases outbreaks must be changed at the World Health Organization, Director General Margaret Chan told the opening of the Executive Board meeting today. She also called for universal health coverage and the implementation of the international health regulation, and for action in the fight against antimicrobial resistance.
WHO Board To Address Reform Progress, R&D Financing, Lobbyists/ Foundations 21/01/2016 by Catherine Saez, Intellectual Property Watch 1 Comment Next week, the World Health Organization Executive Board will hold its biannual meeting. On the agenda are key subjects such as the WHO reform process, sharing of influenza viruses for R&D, and a controversial framework for the WHO’s engagement with actors such as non-governmental organisations, private entities, and foundations. Also on the agenda is the effort to address the growing microbial resistance to antibiotics, and finding a way to finance research and development for diseases affecting primarily developing countries.
Medicines Patent Pool Announces Sub-Licensing Agreements For Hepatitis C Generics 20/01/2016 by Intellectual Property Watch 2 Comments By Jahan ‘Harry’ Taubman-Rezakhanlou for Intellectual Property Watch The Medicines Patent Pool today announced its first round of sub-licensing agreements with four generic manufacturers for the production and sale of a generic line of Bristol-Myers Squibb’s daclatasvir to 112 lower-to middle income countries.
Copyright, Unitary Patent System Lead EU IP Priorities In 2016 19/01/2016 by Dugie Standeford for Intellectual Property Watch 3 Comments Modernisation of EU copyright and intellectual property rights enforcement law tops Europe’s agenda in 2016. Trademark reform legislation approved last year takes effect this year, and a preliminary deal on trade secrets protection is expected to be finalised. Work on the unitary patent system continues, and there’s an increased focus on the issue of patents versus plant breeders’ rights.
50+ US Congress Members Urge Reasonable Licensing Terms For Government-Funded Medical Patents 11/01/2016 by Intellectual Property Watch 2 Comments More than 50 members of the United States Congress today sent a letter urging the US Department of Health and Human Services (HHS) and National Institutes of Health (NIH) to exercise their legal authority to require medical patents that have emerged from government-funded medical research projects to be licensed on reasonable and affordable terms for public use.
TPP, India Most-Read IP-Watch Stories Of 2015 11/01/2016 by William New, Intellectual Property Watch 1 Comment The most-read stories of 2015 on the Intellectual Property Watch website fairly reflected the trends of the year, with the Trans-Pacific Partnership (TPP) agreement, India’s evolving intellectual property rights policies, European Patent Office patents on conventional vegetables, biologics, 3D printing, and some pop culture issues leading the way. In the coming weeks, IP-Watch will review in-depth what’s in store for 2016, already underway. But for now, let’s take a look at last year’s highlights.
UN Initiative On Access To Medicines Calls For Contributions 07/01/2016 by Intellectual Property Watch 1 Comment The United Nations Secretary-General’s newly formed High Level Panel on Access to Medicines launched a call for contributions by stakeholders at the end of December, in an effort it says could transform millions of lives.
University Students Energise Global Campaign For Medical R&D Agreement 05/01/2016 by William New, Intellectual Property Watch 2 Comments The force of hundreds of students worldwide has gathered behind an international effort urging governments to promote research and development in a way that does not result in high-priced medicines. The initiative led by Universities Allied for Essential Medicines (UAEM) seeks to address the longstanding gap in affordable medicines and puts the focus on the World Health Organization, whose members are currently working on this issue.
Alongside WTO Ministerial, Officials Stress Gains On TRIPS And Health 16/12/2015 by Fredrick Nzwili for Intellectual Property Watch 2 Comments NAIROBI, Kenya — On the sidelines of the World Trade Organization Ministerial Summit this week in Nairobi, senior officials from the Kenya government, Joint United Nations Programme on HIV/AIDS (UNAIDS), civil society and others discussed a WTO intellectual property rights amendment on public health to better enable poor nations to access essential medicines.
UN Launches High-Level Panel On Access To Medicines 16/12/2015 by Catherine Saez, Intellectual Property Watch 5 Comments A United Nations high-level panel of experts has set a process in motion to find solutions to increase access to medicines. Following its first meeting last week, the panel will call for proposals to recommend solutions that can promote innovation, but preserve human rights and public health interests.